SCHEMBL24629111

SCHEMBL24629111

C1CN(C2CC3CC2C3)CCN1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
HSD11B1 P28845 1/20 0.31
HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24628143 1.00 CYP2A13 (0.31) CYP2A13SIGMAR1HSD11B1HTR6
SCHEMBL24628148 0.82 SIGMAR1 (0.39) SIGMAR1HTR6
SCHEMBL6971710 0.82 SIGMAR1 (0.36) SIGMAR1HTR6
SCHEMBL21563294 0.74 GNAI3 (0.31)
SCHEMBL14386195 0.74 SIGMAR1 (0.35) SIGMAR1
SCHEMBL23635339 0.71 ADRB1 (0.30)
SCHEMBL17489071 0.70 HTR6 (0.32) HTR6
SCHEMBL27496350 0.68 CYP2A13 (0.47) CYP2A13HSD11B1
SCHEMBL3998603 0.64 CHRNA7 (0.38)
SCHEMBL4484576 0.64 CHRNA7 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022150461-A1 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2022-07-14 WO disclosed